I’ve been saying it for years (and in 3D and Technicolor in my new book Healthcare Beyond Reform): The Standard Model of Healthcare (the traditional unmodified fee-for-service, commodified, defined-benefit payment system) is broken and doomed. It’s...
In 1980, health care in the United States took no more of a bite out of the economy than it did in any other developed country. Then we instituted cost controls. By 2000, U.S. health care cost twice as much as everyone else’s. By 2020 or 2025, we may be back to...
One of the most common ideas in the whole healthcare financing discussion is a moral one. Why, people say, should my taxes and my healthcare premiums go to take care of the huge medical problems of people who don’t take care of themselves? As one commenter on...
[From Hospitals & Health Networks Daily, September 20, 2011] There is fire in the valley and smoke in the mountains. A plague is on the land and danger is afoot. That may be — maybe — the good news. Health care is more unstable than it has been at any time in...
Traditional drug and device research aims to show whether a drug or device has a some positive effect, and doesn’t kill or hurt any more people than not using it. Comparative effectiveness research (CER), in contrast, compares the drug or device with all...
Lindsey Dunn of Becker’s ASC Review reports on what I had to say to the Ambulatory Surgeons meeting in Chicago the other day: In a keynote address to attendees at the 9th Annual Orthopedic, Spine and Pain Management-Driven ASC Conference in Chicago on June 10,...
